Please confirm below to continue:
I confirm that I am a Health Care Professional (HCP) practicing in the United States, or acting on behalf of an HCP.
OR
I am a Formulary Decision Maker (FDM) and/or working on behalf of a public or private payer organization to review scientific information to make drug or device selection or acquisition, formulary management, or coverage and reimbursement decisions on a population basis.
FLORIDA BEST PRACTICE PSYCHOTHERAPEUTIC MEDICATION GUIDELINES FOR ADULTS WERE UPDATED IN 20201
An Expert Panel* has met biennially since 2005 to review and update the Florida Medicaid guidelines
- For each disorder, a nationally recognized expert psychiatrist conducts a full literature review and makes suggestions on revising the guidelines based on the scientific evidence
- The panel discusses and reaches a consensus on the guidelines and proposed revisions
- With evidence-based recommendations for prescribing psychotherapeutic medication to treat bipolar depression, major depressive disorder, and schizophrenia, the guidelines aim to inform and support clinicians in making safe and evidencebased treatment decisions that maximize benefit and minimize harm to patients
Final guidelines are the product of an in-depth literature review, with emphasis on efficacy, safety, level of clinical evidence, and expert consensus on the strength of the evidence
*Expert Panel was composed of nationally recognized experts, academics, medical directors of Florida Medicaid MMA health plans & CMHCs, psychiatrists, primary care providers, and pharmacists.
Recommendations for Schizophrenia from the 2020 Florida Best Practice Psychotherapeutic Medication Guidelines1
2020 Florida Best Practice Pyschotherapeutic Medication Guidelines
HIGHLIGHTS FROM THE 2020 FLORIDA BEST PRACTICE PSYCHOTHERAPEUTIC MEDICATION GUIDELINES FOR SCHIZOPHRENIA
- Lurasidone continues to be recommended as Level 1 treatment for schizophrenia
- LAIs recommended as Level 1 treatment for schizophrenia after trying one oral SGA instead of two oral SGAs, and also selection of an SGA as level 1 treatment for schizophrenia based on sedation and sexual side-effects in addition to other risk factors mentioned in earlier guidelines
LAI=long-acting injectable; SGA=second generation antipsychotic
*Expert Panel was composed of nationally recognized experts, academics, medical directors of Florida Medicaid MMA health plans & CMHCs, psychiatrists, primary care providers, and pharmacists.
Reference: 2019-2020 Florida Best Practice Psychotherapeutic Medication Guidelines for Adults (2020). The University of South Florida, Florida Medicaid Drug Therapy Management Program sponsored by the Florida Agency for Health Care Administration. Available at: www.medicaidmentalhealth.org. Accessed May 2020.
